Metabolic research
What is retatrutide?
Retatrutide is an investigational peptide studied in metabolic research. This guide explains what it is, what laboratory studies have explored, and what to verify before ordering any retatrutide material.
A triple-agonist research peptide
Retatrutide is a single peptide sequence designed to engage three incretin- and metabolic-related receptors simultaneously. It belongs to the same broad research family as GLP-1 receptor molecules, but with a wider receptor profile, which is why it is often described as a triple agonist in study literature.
It remains an investigational compound. It has not been evaluated or approved by the FDA for human consumption or therapeutic use, and legitimate suppliers sell it strictly as a laboratory research material.
What studies have looked at
Published research to date has focused on metabolic parameters in controlled clinical trial settings — body weight, glycemic markers, and lipid measures among them. Those trials used pharmaceutical-grade material administered under medical supervision; they are not a template for self-experimentation.
For researchers sourcing material today, the relevant question is not the trial results but the quality of what actually arrives in the vial.
Why purity is the whole ballgame
Peptide purity varies enormously between suppliers. Material sold as "retatrutide" can contain fillers, synthesis byproducts, truncated sequences, or entirely different compounds. Independent high-performance liquid chromatography (HPLC) and mass spectrometry (MS) testing is the only way to confirm what a vial actually contains.
Every Novera Wellness batch is independently tested to 99% purity, and the batch documentation is available on request before you order. If a supplier cannot produce a current certificate of analysis, that tells you everything you need to know.
Novera Wellness supplies retatrutide for laboratory research use only, with bacteriostatic water included in every vial and batch documentation available before ordering.